Here are six key notes on orthopedic and spine device companies from the past week.
Medtronic will enter into the next phase of its strategic partnership with Mazor Robotics, making a third investment in the company.
Medtronic CEO Omar Ishrak received $15.7 million in compensation for the 2017 fiscal year.
InVivo Therapeutics eliminated 13 positions in a quest to focus attention on the Inspire Study and earn an FDA humanitarian device exemption for the Neuro-Spinal Scaffold.
NuVasive plans to expand its San Diego-based headquarters and add an innovation center to the facility.
MicroPort Orthopedics launched its Procotyl Prime Acetabular Cup System for hip replacement surgery.
Anika Therapeutics, a global orthopedic medicines company, elected Steven Chartier to vice president of regulatory and clinical affairs.